Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
6.00
+0.21 (3.63%)
Jan 21, 2025, 4:00 PM EST - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $270.35 million as of January 22, 2025. Its market cap has decreased by -37.28% in one year.
Market Cap
270.35M
Enterprise Value
-22.34M
1-Year Change
-37.28%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $270.35M, a decrease of -58.90%. That is a compound annual growth rate of -31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 260.89M | -43.73% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |